Classical Hodgkin lymphoma is one of the more frequent lymphomas and is generally
considered a highly curable disease with standard first-line chemotherapy and radiotherapy …

Adjuvant radiation therapy in the management of early stage breast cancer, Hodgkin's
disease, and to a lesser extent other thoracic malignancies has led to a significant …

Importance Hodgkin lymphoma (HL) survivors are at increased risk of cardiovascular
diseases. It is unclear, however, how long the increased risk persists and what the risk …

Background Whether it is possible to reduce the intensity of treatment in early (stage I or II)
Hodgkin's lymphoma with a favorable prognosis remains unclear. We therefore conducted a …

Background: Hodgkin lymphoma (HL) survivors are at increased risk for developing valvular
heart disease (VHD). We evaluated the determinants of the risk and the radiation dose …

We assessed cardiovascular disease (CVD) incidence in 1474 survivors of Hodgkin
lymphoma (HL) younger than 41 years at treatment (1965-1995). Multivariable Cox …

Purpose: To assess long-term cause-specific mortality of young Hodgkin's disease (HD)
patients. Patients and Methods: The study population consisted of 1,261 patients treated for …

In the last half of the century, advances in the systemic therapy of cancer, including
chemotherapy, hormonal therapy, targeted therapy, and immunotherapy have been …

Improvements in early detection, supportive care, and treatment have resulted in an
increasing number of cancer survivors, with a current 5-year relative survival rate for all …

The contribution of specific cancer therapies, comorbid medical conditions, and host factors
to mortality risk after pediatric Hodgkin lymphoma (HL) is unclear. We assessed leading …